• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

OrbiMed Advisors

edit

OrbiMed is ahealthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed’s investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.

Milestones

edit

• 
  OrbiMed Advisors invested in PharmAbcine. (9/16/09)
  Posted 9/29/09 at 1:37am
• 
  OrbiMed Advisors invested in Complete Genomics. (8/24/09)
  Posted 8/24/09 at 12:25pm
• 
  OrbiMed Advisors invested in Enobia Pharma. (8/10/09)
  Posted 9/24/09 at 2:33pm
• 
  OrbiMed Advisors invested in Aragon Pharmaceuticals. (5/27/09)
  Posted 6/17/09 at 1:23pm
• 
  OrbiMed Advisors invested in Cerapedics. (4/2/09)
  Posted 4/13/09 at 12:57pm
• 
  OrbiMed Advisors invested in Singulex. (1/12/09)
  Posted 6/13/09 at 8:21am
• 
  OrbiMed Advisors invested in ARYx Therapeutics. (11/12/08)
  Posted 7/14/09 at 9:53pm
• 
  OrbiMed Advisors invested in Biolex Therapeutics. (10/6/08)
  Posted 6/22/09 at 11:58am
• 
  OrbiMed Advisors invested in Innovative Spinal Technologies. (9/8/08)
  Posted 6/13/09 at 7:02am
• 
  OrbiMed Advisors invested in Glaukos. (8/29/08)
  Posted 6/22/09 at 8:17pm
• 
  OrbiMed Advisors invested in InteKrin. (8/4/08)
  Posted 6/25/09 at 7:47pm
• 
  OrbiMed Advisors invested in Enobia Pharma. (8/07)
  Posted 9/24/09 at 2:33pm
• 
  OrbiMed Advisors invested in Singulex. (6/7/07)
  Posted 6/19/09 at 11:14am
• 
  OrbiMed Advisors invested in Sientra. (4/18/07)
  Posted 9/12/09 at 7:03am
• 
  OrbiMed Advisors invested in ChemoCentryx. (3/22/07)
  Posted 9/12/09 at 9:14am
• 
  OrbiMed Advisors invested in ChemoCentryx. (6/17/04)
  Posted 7/23/09 at 8:08pm

Investments

Videos

Sources

1. PharmAbcine Closes USD $6 Million Series A Financing (bio-medicine.org) [edit]
2. Complete Genomics bags $45M round for sequencing (fiercebiotech.com) [edit]
3. Enobia Raises US$50M from Current Investors in Series C Financing (enobia.com) [edit]
4. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
5. CeraPedics, Inc. Raises $15 Million (devicespace.com) [edit]
6. Singulex Closes $19 Million Financing Round (bio-medicine.org) [edit]
7. ARYx Therapeutics Inc. Announces $21.6 Million Private Placement (investors.aryx.com) [edit]
8. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
9. Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says (xconomy.com) [edit]
10. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
11. InteKrin raises $18.5M for continued work on diabetes drug (deals.venturebeat.com) [edit]
12. enobia.com [edit]
13. Biomarker-diagnostics developer Singulex validates $19M (venturebeat.com) [edit]
14. Sientra, device maker for plastic surgery, raises $85M (deals.venturebeat.com) [edit]
15. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
16. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]